Vaxart Expands Intellectual Property Portfolio with European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart, Inc. European Patent Office granted Vaxart a new patent, extending intellectual property protection for Vaxart’s Norovirus vaccine…